Fig. 2From: Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosisRepresentative histological images for Patient 1 showing complete resolution of bone marrow fibrosis (grade 2 to grade 0)Back to article page